Iambic Therapeutics, Inc.

New Filing
CIK: 0001997038·Biotechnology·DELAWARE·Filed: Sep 9, 2026
Total Offering

$66,500,000

Amount Sold

$65,965,000

Investors

16

First Sale

Aug 14, 2026

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Thomas Miller
Fred Manby
Neil Josephson
Michael Secora
Jishnu Bhattacharjee
Evan Rachlin
R. Jacob Vogelstein
Mary Tagliaferri
William Rastetter
Kurt von Emster
Shalini Sharp
Pete Olson
Samit Hirawat

Company

Iambic Therapeutics, Inc.

5627 OBERLIN DRIVE, SUITE 120

SAN DIEGO, CA, 92121

(619) 330-5499

SEC Filing

0001997038-26-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free